Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial) (FUNCOMBO)
Six-month Endothelial and Microcirculatory Function of the Bioactive Sirolimus-eluting Combo Stent Versus the Polymer-free Biolimus-eluting Biofreedom Stent in Patients With ST-segment Elevation Myocardial Infarction
Sponsor: Institut d'Investigació Biomèdica de Bellvitge
This PHASE4 trial investigates Coronary Microvascular Disease and Endothelial Dysfunction and is currently completed. Institut d'Investigació Biomèdica de Bellvitge leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE4
▶ Show 3 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Feb 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE4
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting PHASE4
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut d'Investigació Biomèdica de Bellvitge
- Spanish Society of Cardiology
For direct contact, visit the study record on ClinicalTrials.gov .